NM_181351.5:c.629-442A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_181351.5(NCAM1):​c.629-442A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.495 in 152,064 control chromosomes in the GnomAD database, including 19,675 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19675 hom., cov: 32)

Consequence

NCAM1
NM_181351.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.690

Publications

10 publications found
Variant links:
Genes affected
NCAM1 (HGNC:7656): (neural cell adhesion molecule 1) This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.709 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NCAM1NM_181351.5 linkc.629-442A>G intron_variant Intron 5 of 19 ENST00000316851.12 NP_851996.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NCAM1ENST00000316851.12 linkc.629-442A>G intron_variant Intron 5 of 19 5 NM_181351.5 ENSP00000318472.8

Frequencies

GnomAD3 genomes
AF:
0.494
AC:
75130
AN:
151944
Hom.:
19630
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.633
Gnomad AMI
AF:
0.283
Gnomad AMR
AF:
0.501
Gnomad ASJ
AF:
0.433
Gnomad EAS
AF:
0.729
Gnomad SAS
AF:
0.498
Gnomad FIN
AF:
0.330
Gnomad MID
AF:
0.449
Gnomad NFE
AF:
0.423
Gnomad OTH
AF:
0.475
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.495
AC:
75234
AN:
152064
Hom.:
19675
Cov.:
32
AF XY:
0.493
AC XY:
36653
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.633
AC:
26271
AN:
41470
American (AMR)
AF:
0.501
AC:
7667
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.433
AC:
1503
AN:
3468
East Asian (EAS)
AF:
0.728
AC:
3757
AN:
5160
South Asian (SAS)
AF:
0.497
AC:
2397
AN:
4826
European-Finnish (FIN)
AF:
0.330
AC:
3489
AN:
10578
Middle Eastern (MID)
AF:
0.449
AC:
132
AN:
294
European-Non Finnish (NFE)
AF:
0.423
AC:
28742
AN:
67952
Other (OTH)
AF:
0.482
AC:
1018
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1864
3729
5593
7458
9322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
664
1328
1992
2656
3320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.455
Hom.:
43405
Bravo
AF:
0.514
Asia WGS
AF:
0.635
AC:
2204
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.77
DANN
Benign
0.50
PhyloP100
0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1821693; hg19: chr11-113077541; API